Raymone Pajarillo

8PUBLICATIONS
107CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

|Jan 06, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad

|Jul 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang

|Dec 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines.

Guido Ghilardi, Luca Paruzzo, Jakub Svoboda

|Aug 24, 2023
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.

Yan Tang, Wei Liu, Siddhant Kadu

|Apr 13, 2023
Apoptosis: a Janus bifrons in T-cell immunotherapy.

Yong Gu Lee, Nicholas Yang, Inkook Chun

Pageof 2

Frequent Collaborators

8 joint publications

Marco Ruella

5 joint publications

Stephen J Schuster

5 joint publications

Patrizia Porazzi

4 joint publications

Yunlin Zhang